New Journey Health Technology Group Co.,LTD (SHE:002219)
China flag China · Delayed Price · Currency is CNY
1.890
0.00 (0.00%)
Oct 30, 2026, 3:04 PM CST

SHE:002219 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,9053,0503,7893,9033,1533,007
Other Revenue
2.612.619.7811.198.138.79
2,9083,0533,7993,9143,1613,016
Revenue Growth
-6.61%-19.64%-2.94%23.83%4.80%7.49%
Cost of Revenue
2,0632,1772,6232,7422,1692,209
Gross Profit
845.01875.471,1761,173992.42807.44
Selling, General & Admin
484.4576.17805.16874.74690.55717.15
Research & Development
15.0613.359.8627.710.240.44
Other Operating Expenses
21.620.2422.4421.1717.9220.38
Operating Expenses
553.06670.7869.21995.87762.51843
Operating Income
291.95204.78307.21176.87229.91-35.56
Interest Expense
-30.27-123.43-135.03-128.48-142.62-230.03
Interest & Investment Income
3.474.5113.7928.9759.6426.63
Currency Exchange Gain (Loss)
----0-
Other Non Operating Income (Expenses)
-134.98-3.47-39.84-68.3940.43-17.08
EBT Excluding Unusual Items
130.1682.39146.138.97187.36-256.03
Impairment of Goodwill
------102.59
Gain (Loss) on Sale of Investments
-3.4-3.410.01---
Gain (Loss) on Sale of Assets
3.580.23-0.07-0.19-0.17-0.67
Asset Writedown
-1.86-1.25-1.19-3.38-1.67-17.12
Legal Settlements
-----0.39-0.3
Other Unusual Items
0.10.019.365.692.4714.33
Pretax Income
128.5777.96154.2311.09187.59-362.39
Income Tax Expense
55.3344.4833.9-28.7722.714.91
Earnings From Continuing Operations
73.2533.48120.3339.86164.89-367.3
Minority Interest in Earnings
-4.94-2.54-5.56-10.89-8.77-4.13
Net Income
68.3130.94114.7728.97156.12-371.43
Net Income to Common
68.3130.94114.7728.97156.12-371.43
Net Income Growth
214.25%-73.04%296.13%-81.44%--
Shares Outstanding (Basic)
3,4273,2923,2883,2553,2661,866
Shares Outstanding (Diluted)
3,4273,2923,2883,2553,2661,866
Shares Change
6.39%0.10%1.02%-0.33%75.08%-0.02%
EPS (Basic)
0.020.010.030.010.05-0.20
EPS (Diluted)
0.020.010.030.010.05-0.20
EPS Growth
195.41%-73.07%292.13%-81.38%--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-14.3436.78131.06111.2546.4778.56
Free Cash Flow Per Share
-0.000.010.040.030.010.04
Gross Margin
29.06%28.68%30.97%29.96%31.40%26.77%
Operating Margin
10.04%6.71%8.09%4.52%7.27%-1.18%
Profit Margin
2.35%1.01%3.02%0.74%4.94%-12.31%
Free Cash Flow Margin
-0.49%1.21%3.45%2.84%1.47%2.60%
EBITDA
428.4357.03480.52384.69385.85127.28
EBITDA Margin
14.73%11.70%12.65%9.83%12.21%4.22%
D&A For EBITDA
136.46152.25173.31207.82155.94162.84
EBIT
291.95204.78307.21176.87229.91-35.56
EBIT Margin
10.04%6.71%8.09%4.52%7.27%-1.18%
Effective Tax Rate
43.03%57.06%21.98%-12.10%-
Revenue as Reported
793.063,0533,7993,9143,1613,016
Advertising Expenses
-185.26265.25187.8671.9258.15